Literature DB >> 21148719

Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk.

Wan-Lun Hsu1, Kelly J Yu, Yin-Chu Chien, Chun-Ju Chiang, Yu-Juen Cheng, Jen-Yang Chen, Mei-Ying Liu, Sheng-Ping Chou, San-Lin You, Mow-Ming Hsu, Pei-Jen Lou, Cheng-Ping Wang, Ji-Hong Hong, Yi-Shing Leu, Ming-Hsui Tsai, Mao-Chang Su, Sen-Tien Tsai, Wen-Yuan Chao, Luo-Ping Ger, Peir-Rong Chen, Czau-Siung Yang, Allan Hildesheim, Scott R Diehl, Chien-Jen Chen.   

Abstract

In the present study, the authors compared the long-term risk of nasopharyngeal carcinoma (NPC) of male participants in an NPC multiplex family cohort with that of controls in a community cohort in Taiwan after adjustment for anti-Epstein-Barr virus (EBV) seromarkers and cigarette smoking. A total of 43 incident NPC cases were identified from the 1,019 males in the NPC multiplex family cohort and the 9,622 males in the community cohort, for a total of 8,061 person-years and 185,587 person-years, respectively. The adjusted hazard ratio was 6.8 (95% confidence interval (CI): 2.3, 20.1) for the multiplex family cohort compared with the community cohort. In the evaluation of anti-EBV viral capsid antigen immunoglobulin A and anti-EBV deoxyribonuclease, the adjusted hazard ratios were 2.8 (95% CI: 1.3, 6.0) and 15.1 (95% CI: 4.2, 54.1) for those positive for 1 EBV seromarker and positive for both seromarkers, respectively, compared with those negative for both EBV seromarkers. The adjusted hazard ratio was 31.0 (95% CI: 9.7, 98.7) for participants who reported a family history of NPC and who were anti-EBV-seropositive compared with individuals without such a history who were anti-EBV-seronegative. The findings suggest that both family history of NPC and anti-EBV seropositivity are important determinants of subsequent NPC risk and that the effect of family history on NPC risk cannot be fully explained by mediation through EBV serologic responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148719      PMCID: PMC3105265          DOI: 10.1093/aje/kwq358

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  32 in total

1.  Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China.

Authors:  J M Yuan; X L Wang; Y B Xiang; Y T Gao; R K Ross; M C Yu
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

Review 2.  Familial influences on adolescent smoking.

Authors:  Shelli Avenevoli; Kathleen Ries Merikangas
Journal:  Addiction       Date:  2003-05       Impact factor: 6.526

3.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

4.  Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

Authors:  Y C Chien; J Y Chen; M Y Liu; H I Yang; M M Hsu; C J Chen; C S Yang
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

5.  Risk factors associated with nasopharyngeal carcinoma.

Authors:  B E Henderson; E Louie; J SooHoo Jing; P Buell; M B Gardner
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

6.  Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong.

Authors:  M C Yu; J H Ho; S H Lai; B E Henderson
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

7.  Familial clustering of nasopharyngeal carcinoma.

Authors:  B W Gajwani; J M Devereaux; J A Beg
Journal:  Cancer       Date:  1980-11-15       Impact factor: 6.860

Review 8.  Cancer epidemiology and control in Taiwan: a brief review.

Authors:  Chien-Jen Chen; San-Lin You; Lih-Hwa Lin; Wan-Lun Hsu; Ya-Wen Yang
Journal:  Jpn J Clin Oncol       Date:  2002-03       Impact factor: 3.019

9.  Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.

Authors:  Amy Pickard; Chien-Jen Chen; Scott R Diehl; Mei-Ying Liu; Yu-Juen Cheng; Wan-Lun Hsu; Brenda Sun; Mow-Ming Hsu; I-How Chen; Jen-Yang Chen; Czau-Siung Yang; Beth L Mittl; Sheng-Ping Chou; Deborah D Ruggles; Alisa M Goldstein; Allan Hildesheim
Journal:  Int J Cancer       Date:  2004-08-10       Impact factor: 7.396

10.  Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.

Authors:  Wan-Lun Hsu; Jen-Yang Chen; Yin-Chu Chien; Mei-Ying Liu; San-Lin You; Mow-Ming Hsu; Czau-Siung Yang; Chien-Jen Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

View more
  8 in total

1.  Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.

Authors:  Zhiwei Liu; Ellen T Chang; Qing Liu; Yonglin Cai; Zhe Zhang; Guomin Chen; Qi-Hong Huang; Shang-Hang Xie; Su-Mei Cao; Jian-Yong Shao; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Liming Liang; Ingemar Ernberg; Thomas L Vaughan; Hans-Olov Adami; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Weimin Ye
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

2.  Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.

Authors:  Nguyen Hoang Viet; Nguyen Quang Trung; Le Thanh Dong; Ly Quoc Trung; J Luis Espinoza
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-03       Impact factor: 4.553

Review 3.  Gut microbiota: Role and Association with Tumorigenesis in Different Malignancies.

Authors:  Altamas Ali; Anam Ara; Manoj Kumar Kashyap
Journal:  Mol Biol Rep       Date:  2022-05-11       Impact factor: 2.742

4.  Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.

Authors:  Su-Mei Cao; Zhiwei Liu; Wei-Hua Jia; Qi-Hong Huang; Qing Liu; Xiang Guo; Teng-Bo Huang; Weimin Ye; Ming-Huang Hong
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

5.  Cancer risk in the relatives of patients with nasopharyngeal carcinoma—a register-based cohort study in Sweden.

Authors:  Z Liu; F Fang; E T Chang; W Ye
Journal:  Br J Cancer       Date:  2015-04-30       Impact factor: 7.640

6.  The incidence and prognosis of nasopharyngeal carcinoma patients with family history.

Authors:  Yansu Wang; Chunying Shen; Xueguan Lu; Chaosu Hu
Journal:  Oncotarget       Date:  2017-10-24

7.  Choline and betaine intakes are associated with reduced risk of nasopharyngeal carcinoma in adults: a case-control study.

Authors:  F-f Zeng; C-h Xu; Y-t Liu; Y-y Fan; X-l Lin; Y-k Lu; C-x Zhang; Y-m Chen
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

8.  Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma.

Authors:  Haiye Jiang; Jian Li; Bin Zhang; Rong Huang; Junhua Zhang; Ziwei Chen; Xueling Shang; Xisheng Li; Xinmin Nie
Journal:  Front Oncol       Date:  2019-12-06       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.